Olof Stranding

Overview

Olof Stranding is a Swedish entrepreneur and investor with experience in various business ventures. He has held leadership roles in several companies, including serving as the Chief Executive Officer and Chief Financial Officer at Acuvi AB from 2013 to 2025. Under his leadership, Acuvi developed world-leading systems and technologies enabling higher precision and increased miniaturization, serving clients in sectors such as Life Sciences, semiconductor industry, and advanced optics. Acuvi's stock was traded on Nasdaq First North Growth Market during his tenure. Prior to his role at Acuvi, Stranding was Head of Business Control at CAE Oxford Aviation Academy and held positions as a controller at Q-Med AB. He is also the Chairman of the Board at ES-Medical AB. Stranding holds a degree in economics from Uppsala University. His investment focus includes technology, healthcare, and industrial automation sectors, with a preference for early-stage to late-stage investments. He has a track record of leading companies through significant growth phases and has been involved in strategic decisions such as targeted emissions and partnerships with financial institutions. Stranding's investment philosophy emphasizes precision, innovation, and scalability, aiming to support companies that drive technological advancements and have a positive impact on society. His extensive experience in business leadership and financial management informs his approach to identifying and nurturing high-potential ventures.

Investment Focus

• Innovative technology solutions
• Scalable business models
• Experienced management teams
• Positive societal impact
• Strong market potential

Portfolio Companies